Literature DB >> 34750734

Cardiovascular autonomic responses during head-up tilt test in newly diagnosed type 2 diabetes.

Esteban Jorge-Galarza1, Margarita Torres-Tamayo1, María Del Rocío Martínez-Alvarado1, Berenice Peña-Aparicio1, Carmen González-Salazar1, Juan Reyes-Barrera1, Manuel Sierra-Beltrán2, Erika Fajardo-Flores2, Andrey Kostin2, J Antonio González-Hermosillo3,4.   

Abstract

BACKGROUND: Autonomic dysfunction is commonly observed in patients with long-standing type 2 diabetes. Previous studies have confirmed the value of both subjectively assessed symptoms and objective measurements of autonomic nervous system function in diagnosing cardiovascular autonomic neuropathy. However, the head-up tilt test (HUTT) has been rarely used to investigate cardiovascular autonomic responses in subjects with high risk of newly diagnosed type 2 diabetes (nT2D).
OBJECTIVE: To evaluate autonomic cardiovascular responses through passive orthostatic challenge along the diabetes continuum.
METHODS: The study population was stratified as normoglycemic (n = 16), prediabetes (n = 20), and nT2D (n = 20). The prevalence of orthostatic intolerance and autonomic cardiovascular responses was evaluated with the Task Force Monitor during a 30-min passive HUTT. Spectral indices of heart rate and blood pressure variability and baroreceptor effectiveness index (BEI) were calculated through the HUTT. BEI was obtained by the sequence method.
RESULTS: There were no differences in the prevalence of orthostatic intolerance or in the indices of heart rate and blood pressure variability among the three groups of study. The BEI was attenuated in the nT2D group in supine rest and throughout HUTT compared with normoglycemic and prediabetes groups. The multivariable linear regression analysis showed that BEI was associated with fasting glucose (β =  - 0.52, p  < 0.001) and HbA1c (β =  - 0.57, p  < 0.001) independently of cardiovascular risk factors.
CONCLUSION: Cardiovascular autonomic neuropathy, expressed as blunted BEI, is the only abnormal autonomic nervous test detected in nT2D, and it was independently associated with fasting glucose and HbA1c values.
© 2021. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.

Entities:  

Keywords:  Baroreceptor sensitivity; Cardiovascular autonomic neuropathy; Orthostatic intolerance; Type 2 diabetes

Mesh:

Substances:

Year:  2021        PMID: 34750734     DOI: 10.1007/s11845-021-02825-7

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   2.089


  26 in total

1.  The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis.

Authors:  Raelene E Maser; Braxton D Mitchell; Aaron I Vinik; Roy Freeman
Journal:  Diabetes Care       Date:  2003-06       Impact factor: 19.112

2.  Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose.

Authors:  Jin-Shang Wu; Yi-Ching Yang; Thy-Sheng Lin; Ying-Hsiang Huang; Jia-Jin Chen; Feng-Hwa Lu; Chih-Hsing Wu; Chih-Jen Chang
Journal:  J Clin Endocrinol Metab       Date:  2007-07-31       Impact factor: 5.958

Review 3.  Pathology and pathogenetic mechanisms of diabetic neuropathy: correlation with clinical signs and symptoms.

Authors:  Soroku Yagihashi; Shin-Ichiro Yamagishi; Ryuichi Wada
Journal:  Diabetes Res Clin Pract       Date:  2007-04-26       Impact factor: 5.602

4.  Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study.

Authors:  J Gerritsen; J M Dekker; B J TenVoorde; F W Bertelsmann; P J Kostense; C D Stehouwer; R J Heine; G Nijpels; R M Heethaar; L M Bouter
Journal:  Diabetologia       Date:  2000-05       Impact factor: 10.122

5.  Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management.

Authors:  Vincenza Spallone; Dan Ziegler; Roy Freeman; Luciano Bernardi; Simona Frontoni; Rodica Pop-Busui; Martin Stevens; Peter Kempler; Jannik Hilsted; Solomon Tesfaye; Phillip Low; Paul Valensi
Journal:  Diabetes Metab Res Rev       Date:  2011-10       Impact factor: 4.876

Review 6.  Cardiac autonomic neuropathy in diabetes: a clinical perspective.

Authors:  Rodica Pop-Busui
Journal:  Diabetes Care       Date:  2010-02       Impact factor: 19.112

7.  Cardiovascular and Cerebral Hemodynamics in Asymptomatic Healthy Subjects With/Without Abnormal Head-up Tilt Test Versus Recurrent Fainters.

Authors:  Antonio González-Hermosillo; Manuel Sierra-Beltrán; Ulises López-Peña; Andrei Kostin; Guadalupe Hernández-Pacheco; Claudia Lerma
Journal:  J Clin Neurophysiol       Date:  2018-01       Impact factor: 2.177

8.  Impedance cardiography: a role in vasovagal syncope diagnosis?

Authors:  Steve W Parry; Michael Norton; Jessie Pairman; Mary Baptist; Katharine Wilton; Pam Reeve; Katy Sutcliffe; Julia L Newton
Journal:  Age Ageing       Date:  2009-09-12       Impact factor: 10.668

9.  Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease.

Authors:  Aaron I Vinik; Tomris Erbas; Carolina M Casellini
Journal:  J Diabetes Investig       Date:  2013-01-29       Impact factor: 4.232

10.  Epidemiology of Type 2 Diabetes - Global Burden of Disease and Forecasted Trends.

Authors:  Moien Abdul Basith Khan; Muhammad Jawad Hashim; Jeffrey Kwan King; Romona Devi Govender; Halla Mustafa; Juma Al Kaabi
Journal:  J Epidemiol Glob Health       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.